354899-91-5Relevant articles and documents
Predicting human serum albumin affinity of interleukin-8 (CXCL8) inhibitors by 3D-QSPR approach
Aureli, Loretta,Cruciani, Gabriele,Cesta, Maria Candida,Anacardio, Roberto,De Simone, Lucio,Moriconi, Alessio
, p. 2469 - 2479 (2007/10/03)
A novel class of 2-(R)-phenylpropionamides has been recently reported to inhibit in vitro and in vivo interleukin-8 (CXCL8)-induced biological activities. These CXCL8 inhibitors are derivatives of phenylpropionic nonsteroidal antiinflammatory drugs (NSAID